CN1134837A - Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" - Google Patents
Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" Download PDFInfo
- Publication number
- CN1134837A CN1134837A CN96101580A CN96101580A CN1134837A CN 1134837 A CN1134837 A CN 1134837A CN 96101580 A CN96101580 A CN 96101580A CN 96101580 A CN96101580 A CN 96101580A CN 1134837 A CN1134837 A CN 1134837A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- raw materials
- chinese patent
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention adopts Smilax glabra, water buffalo's horn, pangolin scales, tuber of multiflower knotweed, licorice root, flavescent sophora root, etc. 21 traditional medicinal herbs as raw materials and makes up the oral Chinese proprietary medicine. Said medicine is safe, reliable and suitable for various types and stages of psoriasis, the clinical effective rate comes up to 96.7%, long-term half year consolidating rate comes up to 90%, and the toxic side-effect is small.
Description
The invention belongs to the psoriatic Chinese patent medicine of a kind of treatment.
Psoriasis also claims psoriasis, and the traditional Chinese medical science belongs to " white arrange ", is a kind of chronic dermatosis of common easy recurrence.Doctor trained in Western medicine does not still have specific drug at present to the treatment of primary disease, and generally with rope and the antitumor drug treatment of supporting one's family, uncertain therapeutic efficacy is cut and is difficult to and consolidates, and the traditional Chinese medical science also has some to treat this sick medicine, but all remains further to be improved its curative effect.
The present invention aims to provide a kind of good effect, the psoriatic Chinese patent medicine of the treatment that toxic and side effects is little.
The technical scheme that realizes above-mentioned purpose is: this Chinese patent medicine is to adopt following Chinese medicine raw materials by weight proportion to make (b is Unit Weight part)
Rhizoma Smilacis Glabrae 25-35b Indigo Naturalis 8-12b Calculus Bovis 5-7b Cornu Bubali 17-23b
Radix Scrophulariae 13-17b Radix Paeoniae Rubra 16-20b Radix Polygoni Multiflori 13-17 Squama Manis 17-23b
Hirudo 6-10b Stigma Croci 4-6b black-snake 25-35b
Periostracum Serpentis 8-12b Scorpio 13-17b Scolopendra 5-7 bar Cortex Dictamni 17-23b
Radix Sophorae Flavescentis 13-17b Radix Pseudostellariae 10-14b
Rhizoma Atractylodis Macrocephalae 13-17b Radix Clematidis 14-18 Nidus Vespae 8-12b Radix Glycyrrhizae 4-8b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine
The traditional Chinese medical science thinks that psoriasis is because heresy of wind and cold, wind heat, rheumatism is outer attacks, and causes battalion to defend and becomes estranged, and the internal injury caused by excess of seven emotions eating and drinking without temperance, and taste are become estranged, due to the qi and blood stagnation, with wind, heat, wet, tremble with fear, heat in blood, blood are dry, blood stasis and deficiency of the liver and kindey etc. are relevant.It is considered herein that wind, heat, the stasis of blood, dryly be main paathogenic factor, thus with heat-clearing and toxic substances removing, promoting blood circulation and cooling blood, dispelling wind for relieving itching, nourshing Yin and drynsessmoistening prescription is main prescription foundation.Rhizoma Smilacis Glabrae, Indigo Naturalis, Calculus Bovis, Stigma Croci, Radix Scrophulariae, black-snake are the product of heat-clearing and toxic substances removing, expelling wind and removing dampness in the side; Cornu Bubali, Radix Paeoniae Rubra have the merit of clearing away heat and cooling blood; Squama Manis, Hirudo, Scorpio, Scolopendra blood circulation and removing stasis, endogenous wind stopping are moisturized; Radix Polygoni Multiflori, Radix Pseudostellariae, the Rhizoma Atractylodis Macrocephalae, the Radix Glycyrrhizae skin moistening that nourishes blood, air making-up and spleen enlivening; Radix Sophorae Flavescentis, Periostracum Serpentis, Cortex Dictamni removing damp to relieve itching; Nidus Vespae, Radix Clematidis expelling wind and removing dampness, full side's compatibility not only takes stopgap measures but also effect a permanent cure.
Routine psoriatic all obtained satisfactory effect surplus this Chinese patent medicine was used for the treatment of 3000, was to the clinical efficacy statistical analysis of 60 routine patient's medications after 90 days below
After three courses of treatment (90 days), total effective rate is 96.7%, and wherein to ordinary and joint type curative effect the best, effective percentage all reaches 100%.In addition, also carried out late result observation, in the effective case of 58 examples of treatment, observation efficacy consolidation half a year is recidivist's 52 examples not, the rate of consolidation is 90%, 6 routine symptoms is only arranged to some extent repeatedly, promptly obtains improvement 1-2 the course of treatment but continue medication, confirm this medicine to psoriasis satisfactory effect not only, and efficacy consolidation.
The model case king builds thread, man, people from Lanzhou, workman
First visit on October 28 in 92 year, the patient claims to suffer from psoriasis more than 9 years, once uses the Chinese and western drugs multi-treatment all invalid, existing erythra dispersed whole body is speckle shape and ring-type, and base coat colour is dim red, the thicker dry squama of last shoe silver gray, clear border, it is not obvious to peel off the back basilar hemorrhage, heavy, indigestion and loss of appetite when light during pruritus, the loose stool, tongue is dim red, ecchymosis is arranged, deep-slow pulse, card belongs to the dry stasis of blood poison of blood.Oral Chinese patent medicine kangyinlin capsule every day of giving that the present invention makes three times, each 6.The further consultation after January of taking medicine, the attenuation of patient's skin rash, pruritus takes a turn for the better, and appetite is promoted, and symptom takes a favorable turn, and takes medicine two months again, and in further consultation on January 29 in 1994, erythra was all eliminated on one's body, and it is normal that skin recovers, and clinical recovery is followed up a case by regular visits to and is recurred half a year again.
This medicine all with the product of the comparatively gentle safety of the property of medicine, is not all found any toxic and side effects through using thousands of examples.
The principles of formulating prescriptions of " heat-clearing and toxic substances removing, promoting blood circulation and cooling blood, dispelling wind for relieving itching, nourshing Yin and drynsessmoistening prescription " of the present invention meet psoriatic occurrence regularity, are the principal elements that obtains desirable curative effect.Simultaneously, psoriasis is in different onset stage clinical manifestation difference, the common basis of differential diagnosis in tcm not consubstantiality card is divided into heat in blood, blood is dry, blood stasis, dialectical the executing of types such as wind and cold controlled, the present invention has then caught wind, heat, the stasis of blood, dry four kinds of main diseases because of, again in conjunction with the characteristics of skin lesion, method with treating both the principal and secondary aspects of a disease, only adopt simple and clear pharmaceutical formulation, promptly caught the principal contradiction of disease, be applicable to psoriatic different differentiation of symptoms and signs for classification of syndrome and each morbidity stage, effective percentage can reach 96.7%, curative effect height and late result are satisfied, consolidate rate long term and reach 90%, toxic and side effects is little simultaneously, low price.
Embodiment 1 present embodiment adopts following Chinese medicinal raw materials (b is Unit Weight part)
Rhizoma Smilacis Glabrae 30b Indigo Naturalis 10b Calculus Bovis 6b Cornu Bubali 20b
Radix Scrophulariae 15b Radix Paeoniae Rubra 18b Radix Polygoni Multiflori 15b Squama Manis 20b
Hirudo 8b Stigma Croci 5b black-snake 30b Periostracum Serpentis 10b
6 Cortex Dictamni 20b of Scorpio 15b Scolopendra Radix Sophorae Flavescentis 15b
Radix Pseudostellariae 12b Rhizoma Atractylodis Macrocephalae 15b Radix Clematidis 16b Nidus Vespae 10b
Radix Glycyrrhizae 6b
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation;
Method for making: above-mentioned raw material of Chinese medicine is chosen decontamination, oven dry, pulverization, the 0.5 gram capsule of packing into.
Usage: the each clothes of adult 6-8 grain, every day 2-3 time, eliminating cold for resuscitation water send down, and child's consumption cuts down according to the circumstance, contraindication in pregnancy.
The course of treatment: continuous use one month was a course of treatment, and for consolidating curative effect, three courses of treatment of logotype are a treatment stage.
Embodiment 2 present embodiments adopt following Chinese medicinal raw materials
Rhizoma Smilacis Glabrae 25b Indigo Naturalis 8b Calculus Bovis 5b Cornu Bubali 17b
Radix Scrophulariae 17b Radix Paeoniae Rubra 20b Radix Polygoni Multiflori 17b Squama Manis 23b
Hirudo 6b Stigma Croci 4b black-snake 25b Periostracum Serpentis 8b
7 Cortex Dictamni 23b of Scorpio 17b Scolopendra Radix Sophorae Flavescentis 17b
Radix Pseudostellariae 10b Rhizoma Atractylodis Macrocephalae 13b Radix Clematidis 14b Nidus Vespae 8b
Radix Glycyrrhizae 8b
Above-mentioned Chinese medicine raw materials by weight proportion is chosen decontamination, and pulverization adds proper honey by " Chinese Pharmacopoeia " medicine pill processing method and makes honeyed pill, every ball 9 grams, the each clothes of adult one ball, every day 2-3 time.
Embodiment 3 present embodiments adopt following Chinese medicinal raw materials
Rhizoma Smilacis Glabrae 35b Indigo Naturalis 12b Calculus Bovis 7b Cornu Bubali 23b
Radix Scrophulariae 13b Radix Paeoniae Rubra 16b Radix Polygoni Multiflori 13b Squama Manis 17b
Hirudo 10b Stigma Croci 6b black-snake 35b Periostracum Serpentis 12b
5 Cortex Dictamni 17b of Scorpio 13b Scolopendra Radix Sophorae Flavescentis 13b
Radix Pseudostellariae 14b Rhizoma Atractylodis Macrocephalae 17b Radix Clematidis 18b Nidus Vespae 12b
Radix Glycyrrhizae 4b
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Claims (2)
1; treat psoriatic Chinese patent medicine; it is characterized in that this medicine adopts following Chinese medicinal raw materials (b is Unit Weight part) Rhizoma Smilacis Glabrae 25-35b Indigo Naturalis 8-12b Calculus Bovis 5-7b Cornu Bubali 17-23b Radix Scrophulariae 13-17b Radix Paeoniae Rubra 16-20b Radix Polygoni Multiflori 13-17 Squama Manis 17-23b Hirudo 6-10b Stigma Croci 4-6b crow black-snake 25-35b Periostracum Serpentis 8-12b Scorpio 13-17b Scolopendra 5-7 bar Cortex Dictamni 17-23b Radix Sophorae Flavescentis 13-17b Radix Pseudostellariae 10-14b Rhizoma Atractylodis Macrocephalae 13-17b Radix Clematidis 14-18 Nidus Vespae 8-12b Radix Glycyrrhizae 4-8b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, Chinese patent medicine according to claim 1; it is characterized in that this medicine adopts 6 Cortex Dictamni 20b of following Chinese medicinal raw materials Rhizoma Smilacis Glabrae 30b Indigo Naturalis 10b Calculus Bovis 6b Cornu Bubali 20b Radix Scrophulariae 15b Radix Paeoniae Rubra 18b Radix Polygoni Multiflori 15b Squama Manis 20b Hirudo 8b Stigma Croci 5b black-snake 30b Periostracum Serpentis 10b Scorpio 15b Scolopendra Radix Sophorae Flavescentis 15b Radix Pseudostellariae 12b Rhizoma Atractylodis Macrocephalae 15b Radix Clematidis 16b Nidus Vespae 10b Radix Glycyrrhizae 6b
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96101580A CN1054528C (en) | 1996-03-26 | 1996-03-26 | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96101580A CN1054528C (en) | 1996-03-26 | 1996-03-26 | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1134837A true CN1134837A (en) | 1996-11-06 |
CN1054528C CN1054528C (en) | 2000-07-19 |
Family
ID=5117128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96101580A Expired - Fee Related CN1054528C (en) | 1996-03-26 | 1996-03-26 | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1054528C (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1060375C (en) * | 1997-04-08 | 2001-01-10 | 刘文江 | Traditional Chinese medicinal preparation for curing psoriasis |
CN1073433C (en) * | 1998-12-06 | 2001-10-24 | 牛余森 | Medicine for psoriasis and preparing method thereof |
CN1089594C (en) * | 1997-12-10 | 2002-08-28 | 叶章照 | Traditional Chinese medicine for curing psoriasis |
US7615239B2 (en) * | 2002-04-15 | 2009-11-10 | Tetsuo Santo | Tea for treating dermatitis comprising herbal extracts |
CN101279054B (en) * | 2008-05-22 | 2010-12-22 | 陈三元 | Chinese medicinal composition for treating psoriasis |
CN102847004A (en) * | 2012-08-31 | 2013-01-02 | 霍山县中医院 | Traditional Chinese medicine for treating psoriasis by using cornu bubali |
CN102961652A (en) * | 2012-11-28 | 2013-03-13 | 马保华 | Chinese medicinal composition for treating psoriasis and application thereof |
CN104000906A (en) * | 2014-06-12 | 2014-08-27 | 济南科纳信息科技有限公司 | Traditional Chinese medicine composition for treating psoriasis |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102755502B (en) * | 2012-08-06 | 2013-12-25 | 廖丽萍 | External use washing liquor for relieving psoriasis |
-
1996
- 1996-03-26 CN CN96101580A patent/CN1054528C/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1060375C (en) * | 1997-04-08 | 2001-01-10 | 刘文江 | Traditional Chinese medicinal preparation for curing psoriasis |
CN1089594C (en) * | 1997-12-10 | 2002-08-28 | 叶章照 | Traditional Chinese medicine for curing psoriasis |
CN1073433C (en) * | 1998-12-06 | 2001-10-24 | 牛余森 | Medicine for psoriasis and preparing method thereof |
US7615239B2 (en) * | 2002-04-15 | 2009-11-10 | Tetsuo Santo | Tea for treating dermatitis comprising herbal extracts |
CN101279054B (en) * | 2008-05-22 | 2010-12-22 | 陈三元 | Chinese medicinal composition for treating psoriasis |
CN102847004A (en) * | 2012-08-31 | 2013-01-02 | 霍山县中医院 | Traditional Chinese medicine for treating psoriasis by using cornu bubali |
CN102847004B (en) * | 2012-08-31 | 2013-11-06 | 霍山县中医院 | Traditional Chinese medicine for treating psoriasis by using cornu bubali |
CN102961652A (en) * | 2012-11-28 | 2013-03-13 | 马保华 | Chinese medicinal composition for treating psoriasis and application thereof |
CN104000906A (en) * | 2014-06-12 | 2014-08-27 | 济南科纳信息科技有限公司 | Traditional Chinese medicine composition for treating psoriasis |
Also Published As
Publication number | Publication date |
---|---|
CN1054528C (en) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
CN101214365B (en) | Chinese medicine composing prescription for treating mastoproliferation | |
CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
CN1840160A (en) | Powder for resisting hyperosteogeny | |
CN1181878C (en) | Detumescence plaster | |
CN1099980A (en) | Chinese-medicinal capsule for treatment of psoriasis | |
CN1134298A (en) | "Dianxianningxiwan" pills-Chinese patent medicine for epilepsy | |
CN1631430A (en) | Chinese medicinal ointment for treating bone diseases | |
CN1312085A (en) | Dermatosis treating medicine | |
CN1089594C (en) | Traditional Chinese medicine for curing psoriasis | |
CN1698735A (en) | Medicine for treating psoriasis | |
CN113769033A (en) | Mongolian medicine prescription for treating hernial disease | |
CN100427132C (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
CN1128667A (en) | Thrombus-eliminating pills | |
CN1879722A (en) | A medicine for treating rheumatic arthritis | |
CN1176708C (en) | Capsule for treating psora | |
CN117959394B (en) | Use of Shenqi Tongmai preparation in preparing medicine for preventing and treating diabetic neuropathy | |
CN1076622C (en) | Chinese medicine for curing nephritis | |
CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
CN1052908C (en) | "Chanhouning" and its preparation method | |
CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease | |
CN1442175A (en) | Chinese medicine for treating mammary gland foliole proliferation | |
CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
CN1216630C (en) | External use medicine for treating vaginitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |